Protagonist Therapeutics Stock Analysis

Protagonist Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Protagonist Therapeutics was at this time reported as 11.13. The company had not issued any dividends in recent years. Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California. Protagonist Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 127 people. To find out more about Protagonist Therapeutics contact Dinesh Patel at 510 474 0170 or learn more at https://www.protagonist-inc.com.

Protagonist Therapeutics Investment Alerts

Protagonist Therapeutics Upcoming and Recent Events

Protagonist Largest EPS Surprises

View All Earnings Estimates

Protagonist Therapeutics Environmental, Social, and Governance (ESG) Scores

Protagonist Stock Institutional Investors

Note, although Protagonist Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Protagonist Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.44 B.

Protagonist Profitablity

The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.68) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.68.

Management Efficiency

Protagonist Therapeutics has return on total asset (ROA) of 0.0248 % which means that it generated a profit of $0.0248 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0899 %, meaning that it created $0.0899 on every $100 dollars invested by stockholders. Protagonist Therapeutics' management efficiency ratios could be used to measure how well Protagonist Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.39 in 2025. Return On Capital Employed is likely to rise to 0.38 in 2025. At this time, Protagonist Therapeutics' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 160.7 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 141.3 M in 2025.

Technical Drivers

As of the 21st of July, Protagonist Therapeutics holds the Semi Deviation of 2.3, coefficient of variation of 714.12, and Risk Adjusted Performance of 0.137. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protagonist Therapeutics, as well as the relationship between them.

Protagonist Therapeutics Price Movement Analysis

Protagonist Therapeutics Insider Trading Activities

Protagonist Therapeutics Outstanding Bonds

Protagonist Therapeutics Predictive Daily Indicators

Protagonist Therapeutics Corporate Filings

Protagonist Therapeutics Forecast Models

Protagonist Therapeutics' time-series forecasting models are one of many Protagonist Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Protagonist Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Protagonist Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Protagonist shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Protagonist Therapeutics. By using and applying Protagonist Stock analysis, traders can create a robust methodology for identifying Protagonist entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Protagonist analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Protagonist analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Protagonist Therapeutics stock analysis indicators help investors evaluate how Protagonist Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Protagonist Therapeutics shares will generate the highest return on investment. By understating and applying Protagonist Therapeutics stock analysis, traders can identify Protagonist Therapeutics position entry and exit signals to maximize returns.

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.